CBLL1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-29465
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunoprecipitation
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
between 1 and 50
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for CBLL1 Antibody
Immunohistochemistry;CBLL1 Antibody[NBP3-29464]
Immunohistochemistry;CBLL1 Antibody[NBP3-29464]Detection of human Hakai by immunohistochemistry. Sample: FFPE section of human breast carcinoma. Antibody: Affinity purified rabbit anti-Hakai used at a dilution of 1:1,000 . Detection: DABApplications for CBLL1 Antibody
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
Tris-citrate/phosphate buffer, pH 7 to 8
Preservative
0.09% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: CBLL1
Alternate Names
Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1, Casitas B-lineage lymphoma-transforming sequence-like protein 1, c-Cbl-like protein 1, E3 ubiquitin-protein ligase Hakai, EC 6.3.2, EC 6.3.2.-, E-cadherin binding protein E7, HAKAIRNF188FLJ23109, MGC163401, MGC163403, RING finger protein 188
Gene Symbol
CBLL1
Additional CBLL1 Products
Product Specific Notices for CBLL1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...